Although the medical relevance in the aforementioned cardiovascular hazard factor alterations by tirzepatide will be assessed from the prepared cardiovascular outcome analyze SURPASS-CVOT ( "kind":"clinical-trial","attrs": "text":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-analysis indicated that tirzepatide did not enhance the danger of MAC... https://codysvxog.blogoscience.com/34128033/about-research-chemicals-vendor